tiprankstipranks

JOINN Laboratories Proposes Capital and Article Amendments

Story Highlights
  • JOINN Laboratories plans to reduce its registered capital due to ceasing stock ownership plans.
  • The company will amend its Articles of Association, pending approval at the 2024 AGM.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JOINN Laboratories Proposes Capital and Article Amendments

An announcement from JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) is now available.

JOINN Laboratories (China) Co., Ltd. has announced a proposed change in its registered capital, reflecting the cessation of its 2021 and 2022 A Shares Employee Stock Ownership Plans. This change involves a reduction in the registered capital and a corresponding decrease in the total number of shares. Additionally, the company plans to amend its Articles of Association to reflect these changes in capital and shareholding structure. These amendments are subject to approval at the company’s 2024 annual general meeting, and the Board has been authorized to manage the necessary regulatory procedures.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the field of laboratory services. It is a joint stock company with a focus on providing scientific research and development services.

YTD Price Performance: 71.12%

Average Trading Volume: 2,560,800

Technical Sentiment Signal: Sell

Current Market Cap: HK$16.72B

Learn more about 6127 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App